Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?Lancet Infect Dis. 2020 10; 20(10):1120-1121.LI
Links
MeSH
Pub Type(s)
Letter
Comment
Language
eng
PubMed ID
32559452
Citation
Afra, T P., et al. "Hydroxychloroquine Use in COVID-19: what Is the Basis for Baseline Tests?" The Lancet. Infectious Diseases, vol. 20, no. 10, 2020, pp. 1120-1121.
Afra TP, T MR, Bishnoi A, et al. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? Lancet Infect Dis. 2020;20(10):1120-1121.
Afra, T. P., T, M. R., Bishnoi, A., & Hafi, N. B. (2020). Hydroxychloroquine use in COVID-19: what is the basis for baseline tests? The Lancet. Infectious Diseases, 20(10), 1120-1121. https://doi.org/10.1016/S1473-3099(20)30472-2
Afra TP, et al. Hydroxychloroquine Use in COVID-19: what Is the Basis for Baseline Tests. Lancet Infect Dis. 2020;20(10):1120-1121. PubMed PMID: 32559452.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
AU - Afra,T P,
AU - T,Muhammed Razmi,
AU - Bishnoi,Anuradha,
AU - Hafi,Na Bishurul,
Y1 - 2020/06/16/
PY - 2020/04/21/received
PY - 2020/05/07/accepted
PY - 2020/6/20/pubmed
PY - 2020/10/2/medline
PY - 2020/6/20/entrez
SP - 1120
EP - 1121
JF - The Lancet. Infectious diseases
JO - Lancet Infect Dis
VL - 20
IS - 10
SN - 1474-4457
UR - https://www.unboundmedicine.com/medline/citation/32559452/Hydroxychloroquine_use_in_COVID_19:_what_is_the_basis_for_baseline_tests
DB - PRIME
DP - Unbound Medicine
ER -